Zhendong Liu
The State Province Key Laboratories Of Biomedicine Pharmaceutics Of China, No. 157 Baojian Street, Nangang District
Harbin, 150001, China
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 16, 2020
The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
Journal: Chinese neurosurgical journal
Published: August 18, 2020
Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Journal: Journal of cellular biochemistry
Published: April 21, 2019
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma.
Journal: Cell death & disease
Published: March 08, 2018
MicroRNA-195 protection against focal cerebral ischemia by targeting CX3CR1.
Journal: Journal of neurosurgery
Published: January 21, 2018
Synergistic regulatory effects of microRNAs on brain glioma cells.
Journal: Molecular medicine reports
Published: April 02, 2016
Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 21, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026